These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 2524553)

  • 1. Studies on the mechanism of protection from acute viral encephalomyelitis by delayed-type hypersensitivity inducer T cell clones.
    Erlich SS; Matsushima GK; Stohlman SA
    J Neurol Sci; 1989 Apr; 90(2):203-16. PubMed ID: 2524553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relapsing encephalomyelitis following transfer of partial immunity to JHM virus.
    Shubin RA; Sussman MA; Fleming JO; Stohlman SA
    Microb Pathog; 1990 May; 8(5):305-14. PubMed ID: 1977071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delayed-type hypersensitivity response in the central nervous system during JHM virus infection requires viral specificity for protection.
    Stohlman SA; Sussman MA; Matsushima GK; Shubin RA; Erlich SS
    J Neuroimmunol; 1988 Sep; 19(3):255-68. PubMed ID: 2842378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo effects of coronavirus-specific T cell clones: DTH inducer cells prevent a lethal infection but do not inhibit virus replication.
    Stohlman SA; Matsushima GK; Casteel N; Weiner LP
    J Immunol; 1986 Apr; 136(8):3052-6. PubMed ID: 2420882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection of mice from a lethal coronavirus infection in the central nervous system by adoptive transfer of virus-specific T cell clones.
    Yamaguchi K; Goto N; Kyuwa S; Hayami M; Toyoda Y
    J Neuroimmunol; 1991 Apr; 32(1):1-9. PubMed ID: 1705943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of Theiler's murine encephalomyelitis virus (TMEV)-specific delayed-type hypersensitivity responses in TMEV-induced demyelinating disease: correlation with clinical signs.
    Clatch RJ; Lipton HL; Miller SD
    J Immunol; 1986 Feb; 136(3):920-7. PubMed ID: 2416841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Class II-restricted T cell responses in Theiler's murine encephalomyelitis virus-induced demyelinating disease. VI. Potentiation of demyelination with and characterization of an immunopathologic CD4+ T cell line specific for an immunodominant VP2 epitope.
    Gerety SJ; Rundell MK; Dal Canto MC; Miller SD
    J Immunol; 1994 Jan; 152(2):919-29. PubMed ID: 7506740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Class I-deficient resistant mice intracerebrally inoculated with Theiler's virus show an increased T cell response to viral antigens and susceptibility to demyelination.
    Pullen LC; Miller SD; Dal Canto MC; Kim BS
    Eur J Immunol; 1993 Sep; 23(9):2287-93. PubMed ID: 8370406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Production and characterization of T cell clones specific for mouse hepatitis virus, strain JHM: in vivo and in vitro analysis.
    Woodward JG; Matsushima G; Frelinger JA; Stohlman SA
    J Immunol; 1984 Aug; 133(2):1016-21. PubMed ID: 6203963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-155 enhances T cell trafficking and antiviral effector function in a model of coronavirus-induced neurologic disease.
    Dickey LL; Worne CL; Glover JL; Lane TE; O'Connell RM
    J Neuroinflammation; 2016 Sep; 13(1):240. PubMed ID: 27604627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cooperation between cytotoxic and helper T lymphocytes in protection against lethal Sendai virus infection. Protection by T cells is MHC-restricted and MHC-regulated; a model for MHC-disease associations.
    Kast WM; Bronkhorst AM; de Waal LP; Melief CJ
    J Exp Med; 1986 Sep; 164(3):723-38. PubMed ID: 3018121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease in mice is influenced by the H-2D region: correlation with TEMV-specific delayed-type hypersensitivity.
    Clatch RJ; Melvold RW; Miller SD; Lipton HL
    J Immunol; 1985 Aug; 135(2):1408-14. PubMed ID: 3925009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Virus-specific T cells in the central nervous system following infection with an avirulent neurotropic mouse hepatitis virus.
    Williamson JS
    Reg Immunol; 1992; 4(3):145-52. PubMed ID: 1338891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Class II-restricted T cell responses in Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease. II. Survey of host immune responses and central nervous system virus titers in inbred mouse strains.
    Clatch RJ; Lipton HL; Miller SD
    Microb Pathog; 1987 Nov; 3(5):327-37. PubMed ID: 2849024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of subtype-specific and cross-reactive helper-T-cell clones recognizing influenza virus hemagglutinin.
    Brown LE; Katz JM; Ffrench RA; Anders EM; White DO
    Cell Immunol; 1987 Oct; 109(1):12-24. PubMed ID: 2958139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T-T cell interaction in the induction of delayed-type hypersensitivity (DTH) responses: vaccinia virus-reactive helper T cell activity involved in enhanced in vivo induction of DTH responses and its application to augmentation of tumor-specific DTH responses.
    Takai Y; Kosugi A; Yoshioka T; Tomita S; Fujiwara H; Hamaoka T
    J Immunol; 1985 Jan; 134(1):108-13. PubMed ID: 3155458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenicity of JHM virus proteins: characterization of a CD4+ T cell epitope on nucleocapsid protein which induces different T-helper cell subsets.
    van der Veen RC
    Virology; 1996 Nov; 225(2):339-46. PubMed ID: 8918920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FTY720 (fingolimod) modulates the severity of viral-induced encephalomyelitis and demyelination.
    Blanc CA; Rosen H; Lane TE
    J Neuroinflammation; 2014 Aug; 11():138. PubMed ID: 25138356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Class II-restricted T cell responses in Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease. III. Failure of neuroantigen-specific immune tolerance to affect the clinical course of demyelination.
    Miller SD; Gerety SJ; Kennedy MK; Peterson JD; Trotter JL; Tuohy VK; Waltenbaugh C; Dal Canto MC; Lipton HL
    J Neuroimmunol; 1990 Jan; 26(1):9-23. PubMed ID: 1688446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The art of survival during viral persistence.
    Stohlman SA; Ramakrishna C; Tschen SI; Hinton DR; Bergmann CC
    J Neurovirol; 2002 Dec; 8 Suppl 2():53-8. PubMed ID: 12491152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.